K-Ras gene status and expression of Ras/mitogen-activated protein kinase (MAPK) signaling molecules in ameloblastomas

Journal of Oral Pathology and Medicine

Volumn 33, Issue 6, 2004, Pages 360-367

  Kumamoto, Hiroyuki ^a   Takahashi, Nobuhiro ^a   Ooya, Kiyoshi ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Ameloblastoma; ERK; K Ras; MEK; Raf

Indexed keywords

GENOMIC DNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PARAFFIN; RAF PROTEIN; RAF1 PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

AMELOBLASTOMA; ARTICLE; BASAL CELL CARCINOMA; BASEMENT MEMBRANE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CODON; CONTROLLED STUDY; DNA SEQUENCE; ENAMEL; ENZYME ACTIVITY; EPITHELIUM CELL; FROZEN SECTION; GENE LOCATION; GENE MUTATION; GRANULAR CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KERATINOCYTE; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; ODONTOGENIC TUMOR; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TISSUE SECTION;

EID: 3142703561     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00141.x     Document Type: Article

References (46)

1. Kramer IRH, Pindborg JJ, Shear M. WHO Histological Typing of Odontogenic Tumours. Berlin: Springer-Verlag, 1992; 11-27.
2. Melrose RJ. Benign epithelial odontogenic tumors. Semin Diagn Pathol 1999; 16: 271-87.
3. Eversole LR. Malignant epithelial odontogenic tumors. Semin Diagn Pathol 1999; 16: 317-24.
4. Sciubba JJ, Fantasia JE, Kahn LB. Tumors and Cysts of the Jaw. Washington, DC: Armed Forces institute of Pathology, 2001: 71-99.
5. Heikinheimo K, Jee KJ, Niini T, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 2002; 81: 525-30.
6. Jaakelainen K, Jee KJ, Leivo I, Saloniemi I, Knuutila S, Heikinheimo K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet 2002; 136: 31-7.
7. Shibata T, Nakata D, Chiba I, et al. Detection of TP53 mutation in ameloblastoma by the use of a yeast functional assay. J Oral Pathol Med 2002; 31: 534-8.
8. Der CJ, Krontiris TG, Cooper GM. Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 1982; 79: 3637-40.
9. Shimizu K, Goldfarb M, Suard Y, et al. Three human transforming genes are related to the viral ras oncogenes. Proc Natl Acad Sci USA 1983; 80: 2112-6.
10. Barbacid M. ras genes. Ann Rev Biochem 1987; 56: 779-827.
11. Capon DJ, Seeburg PH, McGrath JP, et al. Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations. Nature 1983; 304: 507-13.
12. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-54.
13. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
14. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
15. White MA, Nicolette C, Minden A, et al. Cell 1995; 80: 533-41.
16. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J 1995; 9: 726-35.
17. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 1995; 80: 179-85.
18. Kolch W. Meaningful relationships. the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 2000; 351: 289-305.
19. Hajj C, Akoum R, Bradley E, Paquin F, Ayoub J. DNA alterations at proto-oncogene loci and their clinical significance in operable non-small cell lung cancer. Cancer 1990; 66: 733-9.
20. Gulbis B, Galand P. Immunodetection of the p21-ras products in human normal and preneoplastic tissues and solid tumors: a review. Hum Pathol 1993; 24: 1271-85.
21. Oka H, Chatani Y, Hoshino R, et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. Cancer Res 1995; 55: 4182-7.
22. Hoshino R, Chatani Y, Tamori T, et al. Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999; 18: 813-22.
23. Albanell J, Codony-Sevat J, Rojo F, et al. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor α expression in head and heck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments. Cancer Res 2001; 61: 6500-10.
24. Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas. analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 1997; 26: 419-25.
25. Kumamoto H, Ooya K. Immunohistochemical analysis of bcl-2 family proteins in benign and malignant ameloblastomas. J Oral Pathol Med 1999; 28: 343-9.
26. Kumamoto H, Kimi K, Ooya K. Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 2001; 30: 596-602.
27. Kumamoto H, Kinouchi Y, Ooya K. Telomerase activity and telomerase reverse transcriptase (TERT) expression in ameloblastomas. J Oral Pathol Med 2001; 30: 231-6.
28. Kumamoto H, Kimi K, Ooya K. Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 2001; 30: 309-15.
29. Kumamoto H, Yoshida M, Ooya K. Immunohistochemical detection of hepatocyte growth factor, transforming growth factor-β and their receptors in epithelial odontogenic tumors. J Oral Pathol Med 2002; 31: 539-48.
30. Sandros J, Heikinheimo K, Happonen R-P, Stenman G. Expression of p21RAS in odontogenic tumors. APMIS 1991; 99: 15-20.
31. Sunohara M, Tanzawa H, Kaneko Y, Fuse A, Sato K. Expression patterns of Raf-1 suggest multiple roles in tooth development. Calcif Tissue Int 1996; 58: 60-4.
32. Nickolaychuk B, McNicol A, Gilchrist J, Birek C. Evidence for a role of mitogen-activated protein kinases in proliferating and differentiating odontogenic epithelia of inflammatory and developmental cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 93: 720-9.
33. Johnson L, Greenbaum D, Cichowski K, et al. K-ras is an essential gene in the mouse with partial functional overlap with N-ras. Genes Dev 1997; 11: 2468-81.
34. Storm SM, Cleveland JL, Rapp UR. Expression of raf family proto-oncogenes in normal mouse tissues. Oncogene 1990; 5: 345-51.
35. ras activity and consequent prolonged ERK activity. Neuron 1992; 9: 705-17.
36. Cowley S, Paterson H, Kemp P, Marchall C. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 1994; 77: 841-52.
37. Shrestha P, Yamada K, Higashiyama H, Takagi H, Mori M. Epidermal growth factor receptor in odontogenic cysts and tumors. J Oral Pathol Med 1992; 21: 314-7.
38. Heikinheimo K, Voutilainen R, Happonen R-P, Miettinen PJ. EGF receptor and its ligands, EGF and TGF-α, in developing and neoplastic human odontogenic tissues. Int J Dev Biol 1993; 37: 387-96.
39. So F, Daley TD, Jackson L, Wysocki GP. Immunohistochemical localization of fibroblast growth factors FGF-1 and FGF-2, and receptors FGFR2 and FGFR3 in the epithelium of human odontogenic cysts and tumors. J Oral Pathol Med 2001; 30: 428-33.
40. Sivaraman VS, Wang H-Y, Nuovo GJ, Malbon CC. Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 1997; 99: 1478-83.
41. Magi-Galluzzi C, Mishra R, Fiorentino M, et al. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely relate to apoptosis. Laboratory Invest 1997; 76: 37-51.
42. Kupryjanczyk J, Szymanska T, Madry R, et al. Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen. Br J Cancer 2003; 88: 848-54.
43. Fearon ER, Vogelstein. A genetic model for colorectal tumorigenesis. Cell 1990; 61: 759-67.
44. Forrester K, Almoguera C, Han K, Grizzle WE, Peruch M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987; 327: 298-303.
45. Enomoto T, Weghorst CM, Inoue M, Tanizawa O, Rice JM. K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary. Am J Pathol 1991; 139: 777-85.
46. Imamura T, Arima T, Kato H, Miyamoto S, Sasazuki T, Wake N. Chromosomal deletions and K-ras gene mutations in human endometrial carcinomas. Int J Cancer 1992; 51: 47-52.